跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Ondansetron Kabi ondansetron hydrochloride dihydrate 8mg/4mL Solution for Injection glass ampoule - TGA Drug Approval Details
Approvals
/
TGA
/
Ondansetron Kabi ondansetron hydrochloride dihydrate 8mg/4mL Solution for Injection glass ampoule
Approved
STANDARD
Ondansetron Kabi ondansetron hydrochloride dihydrate 8mg/4mL Solution for Injection glass ampoule
Fresenius Kabi Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
ff75168e51077356
Company
Fresenius Kabi Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
ff75168e51077356
Product Name
Ondansetron Kabi ondansetron hydrochloride dihydrate 8mg/4mL Solution for Injection glass ampoule
Artg Id
188775
Artg Name
Ondansetron Kabi ondansetron hydrochloride dihydrate 8mg/4mL Solution for Injection glass ampoule
Sponsor
Fresenius Kabi Australia Pty Ltd
Company Detail Path
/organization/fresenius-kabi-australia-pty-ltd
Artg Date
2012-11-28
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/82751939641771a93d0707312a18b1f2.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/4ec5cd8cbd81eee0a35f564eff1e8fca.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
ff75168e51077356
Type
Standard
Back to TGA Approvals